These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 3989972
1. [Clinical studies with cefoperazone in the biliary disease]. Morinaga T, Furukawa M, Nakata T, Yamada R, Itoh S, Maeda S, Itose K, Ohtsubo M. Jpn J Antibiot; 1985 Jan; 38(1):128-32. PubMed ID: 3989972 [Abstract] [Full Text] [Related]
2. Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits. Hayashi T, Watanabe Y, Kumano K, Kitayama R, Yasuda T, Saikawa I, Totsuka K, Kumada T, Shimizu K. J Antibiot (Tokyo); 1986 May; 39(5):699-712. PubMed ID: 3733519 [Abstract] [Full Text] [Related]
3. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics]. Toyonaga Y, Kurosu Y, Nakamura H, Sugita M, Takahashi T, Hori M. Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740 [Abstract] [Full Text] [Related]
4. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field]. Fujii R, Meguro H, Arimasu O, Mashiko J, Tajima T, Nonaka C, Nagamatsu I, Sato Y, Honjo T, Watanabe A. Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739 [Abstract] [Full Text] [Related]
5. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field]. Iwata S, Sato Y, Iwasaki Y, Hayano S, Wakabayashi R, Kojima Y, Akita H, Sunakawa K, Oikawa T, Osano M. Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863 [Abstract] [Full Text] [Related]
6. [A clinical study of cefoperazone in surgery. Prevention of postoperative infections and transfer into pleural effusion]. Ishihara S, Tomiki K, Tsutsumi M, Ishikawa S. Jpn J Antibiot; 1985 Jun; 38(6):1654-60. PubMed ID: 4046179 [Abstract] [Full Text] [Related]
7. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections]. Koizumi M, Simosegawa T, Yanbe M, Goto Y, Sugawara H, Kanno Y, Kanazawa Y, Kai Y, Sato T, Endou K. Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263 [Abstract] [Full Text] [Related]
8. [Experimental and clinical studies on cefoperazone (author's transl)]. Toyonaga Y, Kurosu Y, Yoshikawa H, Kumagai K, Takahashi T, Hori M. Jpn J Antibiot; 1980 Aug; 33(8):820-40. PubMed ID: 6451729 [Abstract] [Full Text] [Related]
10. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology]. Cho N, Watanabe H, Yoshida K, Moriyama S, Takeda H, Tsukamoto A, Fukunaga K, Kunii K. Jpn J Antibiot; 1984 Oct; 37(10):1939-55. PubMed ID: 6094873 [Abstract] [Full Text] [Related]
11. [Studies on sulbactam/cefoperazone in the field of pediatrics]. Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M. Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865 [Abstract] [Full Text] [Related]
12. [Clinical experience with cefoperazone in respiratory tract infections and studies on its penetration into pleural effusion]. Kajiki A, Yamazaki H, Hasegawa O, Nakashima Y, Kuroiwa A, Harada S, Kido M, Iida K. Jpn J Antibiot; 1983 Dec; 36(12):3456-62. PubMed ID: 6674553 [Abstract] [Full Text] [Related]
13. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections]. Oikawa M, Watanabe I. Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699 [Abstract] [Full Text] [Related]
15. [Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics]. Nakazawa S, Sato H, Narita A, Nakazawa S, Suzuki H, Chikaoka H, Tazoe K. Jpn J Antibiot; 1984 Nov; 37(11):2174-87. PubMed ID: 6098710 [Abstract] [Full Text] [Related]
16. [Clinical investigation of the biliary excretion of cefoperazone in obstructive jaundice]. Matsumoto T, Moriwaki M, Iizuka Y. Jpn J Antibiot; 1986 Oct; 39(10):2795-802. PubMed ID: 3806961 [Abstract] [Full Text] [Related]
17. [Studies on penetration of antibiotics to gallbladder tissue and bile, its surgical significance. Mainly with cefmenoxime]. Tsuburaya H, Watanabe I, Endo S, Oikawa M. Jpn J Antibiot; 1985 Jan; 38(1):31-40. PubMed ID: 3857360 [Abstract] [Full Text] [Related]
18. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space]. Cho N, Kimura T, Suzuki H, Fukunaga K, Kunii K, Komoriyama Y. Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980 [Abstract] [Full Text] [Related]
19. [Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation]. Shima K, Ueno K, Ooto T, Shima Y, Miyata T, Sei T, Yonemura Y, Uemura T, Takano N. Jpn J Antibiot; 1984 Jun; 37(6):966-72. PubMed ID: 6492387 [Abstract] [Full Text] [Related]
20. [Fundamental and clinical studies on cefuzoname in the pediatric field]. Toyonaga Y, Sugita M, Kawamura K, Seo K, Takahashi T, Hori M. Jpn J Antibiot; 1987 Apr; 40(4):843-65. PubMed ID: 3613094 [Abstract] [Full Text] [Related] Page: [Next] [New Search]